# Eli Lilly and Company (LLY) — Q1-2013 Earnings Results

**Report date:** 2013-04-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2013

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 3.9%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.14 | N/A | +7.34% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth driven by new product pipelines. They emphasized the need for continued innovation.

**Key quotes:**

> Management highlighted ongoing investments in R&D as a priority.

> They noted the importance of maintaining market share in a competitive landscape.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.9% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be concerned about the company's future performance without clearer direction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2013_